Demka Sakti is primarily engaged in pharmaceuticals activity. Its headquarters is located in Dki Jakarta. The company was founded in 1984. Demka Sakti, a prominent player in the Indonesian pharmaceutical industry, was founded by a group of visionary entrepreneurs dedicated to improving healthcare standards in the region. The company focuses on the development, manufacturing, and distribution of a wide range of pharmaceutical products, including prescription medications, over-the-counter drugs, and health supplements. Demka Sakti's primary business line is pharmaceuticals, with a secondary focus on health supplements and wellness products. The company operates several branches across Indonesia, ensuring a strong local presence and accessibility to its products. Its main product types include antibiotics, analgesics, and vitamins, marketed under well-known brand names such as DemkaMed and VitaSakti. While Demka Sakti primarily serves the Indonesian market, it has also established a modest presence in neighboring Southeast Asian countries, exporting its products to markets such as Malaysia and the Philippines. The company collaborates with various local healthcare providers and international pharmaceutical firms to enhance its product offerings and expand its market reach. Demka Sakti is a member of several industry associations, including the Indonesian Pharmaceutical Association, which helps it stay abreast of industry trends and regulatory changes. The company is committed to innovation and quality, with a mission to provide affordable and effective healthcare solutions to improve the well-being of communities it serves. With a focus on sustainable growth and customer satisfaction, Demka Sakti aims to become a leading pharmaceutical company in Southeast Asia, driven by its vision of "Health for All, Quality for Life."
Headquarters
Nomor 19 A-B
Central Jakarta; Jakarta;
Postal Code: 10160
Contact Details: Purchase the PT Demka Sakti report to view the information.
Website: http://www.demkasakti.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service